Skip to content

Perception of Cardiovascular Risk

Perception of Cardiovascular Risk: Description of the Phenomenon in Primary Prevention

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06190743
Acronym
CV-RP
Enrollment
271
Registered
2024-01-05
Start date
2023-09-29
Completion date
2024-09-30
Last updated
2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Heart Diseases

Brief summary

The aim of the study is to describe the association between the perception of cardiovascular (CV) risk and the actual CV risk and, secondarily, to detect the actual CV risk to assess the prevalence of clinical risk factors, determined by means of appropriate instruments.

Detailed description

Cardiovascular (CV) disease is the major cause of premature death in adults that carries serious economic consequences. Risk perception for CV disease has been reported as the subjective judgment of the likelihood of having a CV event. Risk perception is an important precursor to adopting a healthy lifestyle. However, both overestimation and underestimation of actual risk due mostly to poor health literacy are common. For these reasons, CV prevention services of health care professionals (e.g., nurses, physicians) should, on the one hand, include screening for the presence of risk factors, and on the other hand, know the CV risk perceptions of those being cared for. The aim of the study is to describe the association between the perception of cardiovascular (CV) risk, investigated by means of the Perception of Risk of Heart Disease Scale and a Likert-5 scale question, and the actual CV risk according to the SCORE2 and, secondarily, to detect the actual CV risk ascertained by the SCORE2 and to assess the prevalence of clinical risk factors (alterations in the lipid, glucose, or anthropometric profile) determined by means of appropriate instruments.

Interventions

OTHERPrevention events organized by participating centers

Cardiovascular disease primary prevention events organized by centers participating in the study where capillary sampling will be performed on subjects to quantify plasma levels of cardiovascular risk factors and validated questionnaires will be administered

Sponsors

IRCCS San Raffaele
CollaboratorOTHER
Centro Cardiologico Monzino
CollaboratorOTHER
Istituto Auxologico Italiano
CollaboratorOTHER
Istituti Ospedalieri Bergamaschi Srl
CollaboratorOTHER
Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria
Lead SponsorOTHER

Study design

Observational model
CASE_CROSSOVER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 69 Years

Inclusion criteria

* an age between 18 and 69 years of age * subscription to informed consent.

Exclusion criteria

* patients with a positive history of hospitalization due to CV pathology at the time of enrollment; * patients with ongoing relevant cognitive debilitation (Six Item Screener score \< 4)

Design outcomes

Primary

MeasureTime frameDescription
Duke-UNC Functional Social Support QuestionnaireScreeningStrength of affective support derived from people close to the enrolled subjects
Perception of Risk of Heart Disease ScaleScreeningIndividual perception of the likelihood of having heart disease
Systemic Coronary Risk Estimation version2ScreeningIndividual real risk at 10 years, both for fatal CV events, and also for nonfatal CV events (myocardial infarction and stroke) in apparently healthy subjects
Patient Health Questionnaire-4ScreeningScreening for the uptake of psychological symptoms of anxiety or depression in the primary care setting

Secondary

MeasureTime frameDescription
Lipid panelScreeningLipid panel measurement
GlucoseScreeningGlucose measurement
HeightScreeningHeight measurement
WeightScreeningWeight measurement

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026